Literature DB >> 11339349

Immune responses to DNA in normal and aberrant immunity.

D S Pisetsky1.   

Abstract

Because of structural microheterogeneity, DNA can exert powerful effects that lead to immune system activation as well as antibody induction. These activating effects resemble those ofendotoxin and result from sequences that occur much more commonly in bacterial DNA than in mammalian DNA. In contrast, mammalian DNA can inhibit the response to bacterial DNA as well as other stimuli and may serve a counterregulatory role during infection. The recognition of the immune effects of DNA is relevant to the pathogenesis of a variety of infectious and inflammatory diseases including systemic lupus erythematosus, a prototypic autoimmune disease characterized by anti-DNA autoantibodies.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11339349     DOI: 10.1385/IR:22:2-3:119

Source DB:  PubMed          Journal:  Immunol Res        ISSN: 0257-277X            Impact factor:   4.505


  28 in total

1.  Influence of backbone chemistry on immune activation by synthetic oligonucleotides.

Authors:  D S Pisetsky; C F Reich
Journal:  Biochem Pharmacol       Date:  1999-12-15       Impact factor: 5.858

2.  Sequence motifs in adenoviral DNA block immune activation by stimulatory CpG motifs.

Authors:  A M Krieg; T Wu; R Weeratna; S M Efler; L Love-Homan; L Yang; A K Yi; D Short; H L Davis
Journal:  Proc Natl Acad Sci U S A       Date:  1998-10-13       Impact factor: 11.205

3.  The influence of DNA sequence on the immunostimulatory properties of plasmid DNA vectors.

Authors:  M K Wloch; S Pasquini; H C Ertl; D S Pisetsky
Journal:  Hum Gene Ther       Date:  1998-07-01       Impact factor: 5.695

4.  Patterns of heavy and light chain utilization in the antibody response to single-stranded bacterial DNA in normal human subjects and patients with systemic lupus erythematosus.

Authors:  C R Robertson; G S Gilkeson; M M Ward; D S Pisetsky
Journal:  Clin Immunol Immunopathol       Date:  1992-01

Review 5.  Immune activation by bacterial DNA: a new genetic code.

Authors:  D S Pisetsky
Journal:  Immunity       Date:  1996-10       Impact factor: 31.745

Review 6.  Antibodies to DNA. A perspective.

Authors:  W Emlen; D S Pisetsky; R P Taylor
Journal:  Arthritis Rheum       Date:  1986-12

7.  Deficient expression of antibodies specific for bacterial DNA by patients with systemic lupus erythematosus.

Authors:  D S Pisetsky; D M Drayton
Journal:  Proc Assoc Am Physicians       Date:  1997-05

8.  Inhibition of murine macrophage IL-12 production by natural and synthetic DNA.

Authors:  D S Pisetsky; C F Reich
Journal:  Clin Immunol       Date:  2000-09       Impact factor: 3.969

9.  The influence of DNA structure on the in vitro stimulation of murine lymphocytes by natural and synthetic polynucleotide antigens.

Authors:  J P Messina; G S Gilkeson; D S Pisetsky
Journal:  Cell Immunol       Date:  1993-03       Impact factor: 4.868

10.  Induction of anti-double stranded DNA antibodies in normal mice by immunization with bacterial DNA.

Authors:  G S Gilkeson; J P Grudier; D G Karounos; D S Pisetsky
Journal:  J Immunol       Date:  1989-03-01       Impact factor: 5.422

View more
  5 in total

1.  The role of macrophages in the in vitro generation of extracellular DNA from apoptotic and necrotic cells.

Authors:  Jin-Jung Choi; Charles F Reich; David S Pisetsky
Journal:  Immunology       Date:  2005-05       Impact factor: 7.397

2.  The role of microparticles in the generation of immune complexes in murine lupus.

Authors:  Anirudh J Ullal; David S Pisetsky
Journal:  Clin Immunol       Date:  2012-10-13       Impact factor: 3.969

3.  Systemic Lupus Erythematosus: Definitions, Contexts, Conflicts, Enigmas.

Authors:  Ole Petter Rekvig
Journal:  Front Immunol       Date:  2018-03-01       Impact factor: 7.561

Review 4.  Cooperation of Oligodeoxynucleotides and Synthetic Molecules as Enhanced Immune Modulators.

Authors:  Shireen Nigar; Takeshi Shimosato
Journal:  Front Nutr       Date:  2019-08-27

Review 5.  Opportunities and challenges for the clinical translation of structured DNA assemblies as gene therapeutic delivery and vaccine vectors.

Authors:  Marina A Dobrovolskaia; Mark Bathe
Journal:  Wiley Interdiscip Rev Nanomed Nanobiotechnol       Date:  2020-07-15
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.